Nuvigil is a brand-name medication approved to treat sleepiness associated with narcolepsy, obstructive sleep apnea, and shift work sleep disorder [1]. The active ingredient in Nuvigil is armodafinil [2].
What is armodafinil used for?
Armodafinil is prescribed to improve wakefulness in adults experiencing excessive sleepiness due to narcolepsy, obstructive sleep apnea (OSA), or shift work sleep disorder (SWSD) [1]. It is not intended as a replacement for conventional treatments like continuous positive airway pressure (CPAP) for OSA [1].
How does armodafinil work?
The exact mechanism by which armodafinil promotes wakefulness is not fully understood [1]. However, it is believed to affect certain neurotransmitter systems in the brain, influencing alertness and arousal [1].
When does Nuvigil's patent expire?
Patent information for Nuvigil can be found on DrugPatentWatch.com [3]. Patents for pharmaceutical products are complex and can involve multiple patents covering different aspects of the drug, such as composition, manufacturing, and method of use [4].
Can generic versions of Nuvigil be made?
The availability of generic versions of Nuvigil depends on the expiration of its patents and any associated market exclusivities [4]. Once these protections expire, other companies may be able to develop and market generic versions of armodafinil, provided they receive regulatory approval [4].
What are the side effects of Nuvigil?
Common side effects of Nuvigil include headache, nausea, dizziness, insomnia, anxiety, and decreased appetite [1]. Serious but less common side effects can include severe rash, allergic reactions, and psychiatric symptoms such as hallucinations or mania [1].
How does Nuvigil compare to Provigil?
Nuvigil (armodafinil) and Provigil (modafinil) are both wakefulness-promoting agents, but they differ in their active ingredients and pharmacokinetics [5]. Armodafinil is the R-enantiomer of modafinil, meaning it is a purer form of one of the two mirror-image molecules that make up modafinil [5]. This difference can lead to armodafinil having a longer duration of action in some individuals [5]. Both drugs are used for similar sleep disorders [1][5].
What clinical data supports Nuvigil's use?
Clinical trials have demonstrated armodafinil's efficacy in improving wakefulness in patients with narcolepsy, OSA, and SWSD [1]. These studies typically assess sleepiness using standardized scales and objective measures of wakefulness [1].
Where can I find more information about Nuvigil and its patents?
DrugPatentWatch.com provides resources and data regarding drug patents, including those for Nuvigil [3].
Sources
[1] https://www.fda.gov/drugs/postmarket-drug-safety-information-for-patients-and-providers/nuvigil-armodafinil-safety-information
[2] https://www.drugpatentwatch.com/drug/nuvigil
[3] https://www.drugpatentwatch.com/
[4] https://www.drugpatentwatch.com/patent-basics
[5] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624512/